Cannabis, tobacco smoking, and lung function: A cross-sectional observational study in a general practice population

British Journal of General Practice

Volumn 65, Issue 631, 2015, Pages e89-e95

  Macleod, John ^a   Robertson, Roy ^b,d   Copeland, Lorraine ^c   McKenzie, James ^c   Elton, Rob ^d   Reid, Peter ^e  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Department of Addiction Medicine ^*  (United Kingdom)

^c Muirhouse Medical Group   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cannabis; General practice; Lung function tests; Respiratory; Signs and symptoms

Indexed keywords

CANNABIS;

ADOLESCENT; ADULT; AGED; ARTICLE; CANNABIS SMOKING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENERAL PRACTICE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; SPIROMETRY; TOBACCO USE; ADVERSE EFFECTS; FORCED EXPIRATORY VOLUME; LUNG; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; QUESTIONNAIRE; SCOTLAND; SMOKING; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CANNABIS; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; GENERAL PRACTICE; HUMANS; LUNG; MALE; MIDDLE AGED; PREVALENCE; SCOTLAND; SMOKING; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84921760406     PISSN: 09601643     EISSN: 14785242     Source Type: Journal    
DOI: 10.3399/bjgp15X683521     Document Type: Article

References (25)

1. National Institute for Health and Clinical Excellence. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update). NICE guidelines [CG101]. https://www.nice.org.uk/guidance/cg101 (accessed 9 Dec 2014).
2. United Nations Office on Drugs and Crime. World Drug Report 2010. http://www.unodc.org/unodc/data-and-analysis/WDR-2010.html (accessed 25 Nov 2014).
3. Kuepper R, van Os J, Lieb R, et al. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 2011; 342: d738.
4. Tashkin DP, Coulson AH, Clark VA, et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis 1987; 135: 209-216.
5. Bloom JW, Kaltenborn WT, Paoletti P, et al. Respiratory effects of non-tobacco cigarettes. BMJ 1987; 295: 1516-1518.
6. Tashkin DP, Shapiro BJ, Lee YE, Harper CE. Subacute effects of heavy marihuana smoking on pulmonary function in healthy men. N Engl J Med 1976; 294: 125-129.
7. Sherrill DL, Krzyzanowski M, Bloom JW, Lebowitz D. Respiratory effects of nontobacco cigarettes: a longitudinal study in general population. Int J Epidemiol 1991; 20(1): 132-137.
8. Taylor D, Poulton R, Moffitt TE, et al. The respiratory effects of cannabis dependence in young adults. Addiction 2000; 95: 1169-1677.
9. Taylor DR, Fergusson DM, Milne BJ, et al. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 2002; 97: 1055-1061.
10. Moore BA, Auguston EM, Moser RP, Budney AJ. Respiratory effects of marijuana and tobacco use in a US sample. J Gen Int Med 2004; 20: 33-37.
11. Aldington S, Williams M, Nowitz M, et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007; 62: 1058-1063.
12. Tan WC, Lo C, Jong A, et al. Marijuana and chronic obstructive lung disease: a population-based study. CMAJ 2009: 180(8): 814-820.
13. Pletcher MJ, Vittinghoff E, Kalhan R, et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA 2012; 307: 173-181.
14. Robertson R, Miller P, Anderson R. Cannabis use in the community. Br J Gen Pract 1996; 46: 671-674.
15. Doll R, Bradford Hill A. The mortality of doctors in relation to their smoking habits. BMJ 1954; 1(4877): 1451-1455.
16. University of Bristol. The Avon Longitudinal Study of Parents and Children. http://www.bristol.ac.uk/alspac/ (accessed 9 Dec 2014).
17. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/about/major/nhanes/ questexam.html (accessed 25 Nov 2014).
18. Fletcher CM (Chairman). Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ 1960; 2: 1665.
19. SIMD. Scottish Index of Multiple Deprivation. http://simd.scotland.gov.uk/ publication-2012/ (accessed 9 Dec 2014).
20. Quanjer P, Dalhuisen A, van Zomeren B. Standardisation of lung function tests. Report of the Working Party for Standardisation of Lung Function Tests. European Community for Coal and Steel. Bull Eur Physiopathol Respir 1983; 19: 45-51.
21. American Thoracic Society. Standardisation of spirometry: 1994 update. Am J Respir Crit Care Med 1994; 152: 1107-1136.
22. Martin GW, Wilkinson DA, Kapur BM. Validation of self-reported cannabis use by urine analysis. Addict Behav 1988; 13: 147-150.
23. Akinci IH, Tarter RE, Kirisci L. Concordance between verbal report and urine screen of recent marijuana use in adolescents. Addict Behav 2001; 26: 613-619.
24. Tashkin DP. Does cannabis use predispose to chronic airflow obstruction? Eur Respir J 2010; 35: 3-5.
25. Lee MH, Hancox RJ. Effects of smoking cannabis on lung function. Expert Rev Respir Med 2011; 4: 537-546.